Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Withdrawn 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Brain Neoplasms 2

Interventions

pembrolizumab 61Cisplatin 37Carboplatin 23Radiotherapy 21Cetuximab 19Magnetic Resonance Spectroscopy 18Paclitaxel 17Specimen Handling 13Docetaxel 12Fluorouracil 11Nivolumab 10tislelizumab 9Surgical Procedures, Operative 8Radiotherapy, Intensity-Modulated 7Radiation 7cemiplimab 6Standard of Care 6Platinum 6Chemoradiotherapy 6Biopsy 61,2-diaminocyclohexaneplatinum II citrate 6toripalimab 5Drug Therapy 5130-nm albumin-bound paclitaxel 5atezolizumab 4Taxes 4Ipilimumab 4Immunotherapy 4Fluorodeoxyglucose F18 4Cyclophosphamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Squamous Cell Carcinoma of Head and Neck × fluoromisonidazole × Clear all
NCT06087614 2025-01-17

DE-HyART

Rajiv Gandhi Cancer Institute & Research Center, India

Phase 2 Recruiting
124 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05996432 2024-09-23

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Recruiting
48 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡